Annual Reports

Our highlights 2022


Our vision: Being "Pioneers for sustainable health"

In this annual report, you can read just how successfully we are translating this vision into reality through our research. 


»Models of Lung Disease«

Our international Fraunhofer seminar "Models of Lung Disease" celebrated its 20th anniversary in 2022.

People in research


Selina Schrader

“It is wonderful and fascinating to be involved in research that holds tremendous potential for the future, such as the development of vaccines and cancer therapies.“


Annika Klauke

“I want to pass my own knowledge and to enthuse young people about the the multifaceted and exciting job of  laboratory technician.”


Marvin Thienel

“My team and I together provide the technical environment that allows our scientists to do their research as smoothly as possible.”

For more than four decades, we have been developing solutions for human health


Malignant disease

The Fraunhofer ITEM Division of Personalized Tumor Therapy in Regensburg aims to understand a patient’s individual condition, establish appropriate diagnostics, advance prevention and optimize therapies.

Medical and pharmaceutical engineering

Our focus is on new inhalation technologies and on novel technologies for administration of therapeutic aerosols by smart drug/device combination products.


Lung research

Research for healthy lungs: Airway research has been a focus at Fraunhofer ITEM ever since the institute was founded. 


Our researchers develop methods for preparation, analysis and visualization of biomedical data, as well as data models and data analysis pipelines. The focus is on the mapping of cellular and regulatory processes and their translation into applications.


Immunology and infection research

The development, formulation and mode of delivery of anti-infective agents, for example for inhaled administration as drug aerosols, are research topics of current interest at the institute.



Based on the next generation risk assessment concept, Fraunhofer ITEM develops new assessment strategies to provide predictive models for assessing the safety of compounds, active pharmaceutical ingredients and drugs.


RNA technologies

RNA-based therapeutics are a drug class with huge potential for medicine. Fraunhofer ITEM researchers develop novel drugs and methods for RNA-based therapeutic concepts.

Behind the scenes

Our Annual Report allows you to get an insight into our research activities and objectives, but also into the way we work and the people behind all this. Our Annual Report each year gives an account of the work done in our different business areas and of selected research results. If you prefer to read a printed version of our Annual Report, please subscribe to the printed version. We will be pleased to send you a copy and hope you will enjoy reading it.


Press and media – would you like to read more?

Up-to-date information throughout the year

A chapter in our Annual Report documents the "Names, dates and facts" for this particular year. For up-to-date informationen in the individual subject areas, please click below on the corresponding link:

Subscribe or unsubscribe

Please click below to subscribe to our Annual Report – the printed version or e-paper or both – or to cancel your subscription.

Your contact for press and public relations

Cathrin Nastevska

Contact Press / Media

Dr. Cathrin Nastevska

Public Relations Manager

Phone +49 511 5350-225